Skip to main content
Log in

Kinetic studies of bone and mineral metabolism during treatment with (3-amino-1-hydroxypropylidene)-1,1-bisphosphonate (APD) in rats

  • Laboratory Investigation
  • Published:
Calcified Tissue International Aims and scope Submit manuscript

Summary

Dose-related effects of APD on bone metabolism and Ca homeostasis were studied in rats. The experimental approach consisted of longitudinal and cross-sectional observations, aiming at a kinetic interpretation. Bone and cartilage resorption was inhibited within 2–8 days at doses between 0.16 and 16 µmol/kg body weight/day. This was followed by changes in bone apposition that needed at least 23 days for a maximal effect. The time lag created a transient dissociation between resorption and apposition resulting in excess Ca and P retention, adding to increased metaphyseal bone mass. At high doses of APD (≥40 µmol/kg/day) the mineral content of new matrix decreased, associated with impairment of longitudinal growth of long bones. It is concluded that the lower doses of APD inhibited resorption of bone and cartilage, possibly by physicochemical stabilization of bone mineral, whereas the effect on bone apposition was due to a cellular homeostatic mechanism. Inhibition of growth and of matrix calcification, requiring much higher doses, may be due to a direct, toxic effect on bone cells. The modes of action of APD are discussed in relation to EHDP and Cl2MDP.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Francis, M.D.: The inhibition of calcium hydroxyapatite growth by polyphosphonates and polyphosphates, Calcif. Tissue Res.3:151–162, 1969

    Article  CAS  PubMed  Google Scholar 

  2. Fleisch, H., Russell, R.G.G., Francis, M.D.: Diphosphonates inhibit hydroxyapatite dissolutionin vitro and bone resorption in tissue culture andin vivo, Science165:1262–1264, 1969

    CAS  PubMed  Google Scholar 

  3. Gasser, A.B., Morgan, D.B., Fleisch, H.A., Richelle, L.J.: The influence of two diphosphonates on calcium metabolism in the rat, Clin. Sci.43:31–45, 1972

    CAS  PubMed  Google Scholar 

  4. Russell, R.G.G., Kislig, A.-M., Casey, P.A., Fleisch, H., Thornton, J., Schenk, R., Williams, D.A.: Effect of diphosphonates and calcitonin on the chemistry and quantitative histology of rat bone, Calcif. Tissue Res.11:179–195, 1973

    CAS  PubMed  Google Scholar 

  5. Schenk, R., Merz, W.A., Mühlbauer, R., Russell, R.G.G., Fleisch, H.: Effect of ethane-1-hydroxy-1,1-diphosphonate (EHDP) and dichloromethylene diphosphonate (Cl2MDP) on the calcification and resorption of cartilage and bone in the tibial epiphysis and metaphysis of rats, Calcif. Tissue Res.11:196–214, 1973

    CAS  PubMed  Google Scholar 

  6. Smith, R., Russell, R.G.G., Woods, C.G., Bishop, M.: Paget's disease of bone: experience with a diphosphonate (disodium etidronate) in treatment, Q. J. Med., New SeriesXVII:235–256, 1973

    Google Scholar 

  7. Altman, R.D., Johnston, C.C., Khairi, M.R.A., Wellman, H., Serafim, A.N., Sankey, R.R.: Influence of disodium etidronate on clinical and laboratory manifestations of Paget's disease of bone (osteitis deformans), N. Engl. J. Med.289:1379–1384, 1973

    Article  CAS  PubMed  Google Scholar 

  8. Jowsey, J., Holley, K.E., Linman, J.W.: The effect of sodium etidronate in adult cats, J. Lab. Clin. Med.76:126–133, 1970

    CAS  PubMed  Google Scholar 

  9. King, W.R., Francis, M.D., Michael, W.R.: Effect of disodium ethane-1-hydroxy-1,1-diphosphonate on bone formation. Clin. Orthop.78:251–270, 1970

    Google Scholar 

  10. Russell R.G.G., Smith, R., Preston, C., Walton, R.J., Woods, C.G.: Diphosphonates in Paget's disease, Lanceti:894–898, 1974

    Google Scholar 

  11. Guncaga, J., Lauffenburger, Th., Lentner, Ch., Dambacher, M.A., Haas, H.G.: Diphosphonate treatment of Paget's disease of bone, Horm. Metab. Res.6:62–69, 1974

    Article  CAS  PubMed  Google Scholar 

  12. DeVries, H.R., Bijvoet, O.L.M.: Results of prolonged treatment of Paget's disease of bone with disodium ethane-1-hydroxy-1,1-diphosphonate (EHDP), Neth. J. Med.17:281–298, 1974

    CAS  Google Scholar 

  13. Miller, S.C., Jee, W.S.S.: The comparative effects of dichloromethylene diphosphonate (Cl2MDP) and ethane-1-hydroxy-1,1-diphosphonate (EHDP) on growth and modeling of the rat tibia, Calcif. Tissue Res.23:207–214, 1977

    Article  CAS  PubMed  Google Scholar 

  14. Lemkes, H.H.P.J., Reitsma, P.H., Frijlink, W.B., Verlinden-Ooms, H., Bijvoet, O.L.M.: A new diphosphonate: dissociation between effects on cells and mineral in rats and a preliminary trial in Paget's disease. In S.G. Massry, E. Ritz, A. Rapado (eds.): Homeostasis of Phosphate and Other Minerals. pp. 459–469. Plenum Press, New York, 1978

    Google Scholar 

  15. Johnson, L.C.: Morphologic analysis of pathology: the kinetics of disease and general biology of bone. In H.M. Frost (ed): Bone Biodynamics, pp. 543–654. J. & A. Churchill, London 1964

    Google Scholar 

  16. Frost, H.M.: Dynamics of bone remodeling. In H.M. Frost (ed.): Bone Biodynamics, pp. 315–333. J & A. Churchill, London, 1964

    Google Scholar 

  17. Rasmussen, H., Bordier, P.: The Physiological and Cellular Basis of Metabolic Bone Disease. Williams & Wilkins, Baltimore, 1974

    Google Scholar 

  18. Prockop, D.J., Udenfriend, S.: A specific method for the analysis of hydroxyproline in tissues and urine, Anal. Biochem.1:228–239, 1960

    Article  CAS  PubMed  Google Scholar 

  19. Grogan, C.H., Cahmann, H.J., Lehco, E.: Micro-determination of chromium in small samples of various biological media. Anal. Chem.27:983–986, 1955

    Article  CAS  Google Scholar 

  20. Reynolds, J.J.: Skeletal tissue in culture. In G.H. Bourne (ed).: The Biochemistry and Physiology of Bone, Vol. I, pp. 69–126. Academic Press, New York, 1972

    Google Scholar 

  21. Juva, K., Prockop, D.J.: Modified procedure for the assay of3H-or14C-labeled hydroxyproline, Anal. Biochem.15:77–83, 1966

    Article  CAS  PubMed  Google Scholar 

  22. Wöltgens, J.H.M., Bonting, S.L., Bijvoet, O.L.M.: Relationship of inorganic pyrophosphatase and alkaline phosphatase activities in hamster molars, Calcif. Tissue Res.5:333–343, 1970

    Article  PubMed  Google Scholar 

  23. Fishman, W.H.: The influence of steroids onβ-glucuronidase of mouse kidneys. In R.I. Dorfman (ed): Methods in Hormone Research, Vol. IV, pp. 273–326. Academic Press, New York, 1965

    Google Scholar 

  24. Fiske, C.H., Subbarow, Y.: The colorimetric determination of phosphorus, J. Biol. Chem.66:375–400, 1925

    CAS  Google Scholar 

  25. TeVelde, J., Burckhardt, R., Kleiverda, K., Leenheers-Binmendijk, L., Sommerfelt, W.: Methylmethacrylate in histopathology, Histopathology1:319–330, 1977

    Google Scholar 

  26. Goldner, J.A.: A modification of the Masson trichrome technique for routine laboratory purpose, Am. J. Pathol.14:237–243, 1938

    CAS  PubMed  Google Scholar 

  27. Vaes, G.: La Résorption Osseuse et l'Hormone Parathyroidienne. De Visscher, Bruxelles, 1967

    Google Scholar 

  28. Fleisch, H., Russell, R.G.G., Bisaz, S., Mühlbauer, R.C., Williams, D.A.: The inhibitory effect of phosphonates on the formation of calcium phosphate crystalsin vitro and on aortic and kidney calcificationin vivo, Eur. J. Clin. Invest.1:12–18, 1970

    CAS  PubMed  Google Scholar 

  29. Potokar, M., Schmidt-Dunker, M.: The inhibitory effect of new diphosphonic acids on aortic and kidney calcificationin vivo, Atherosclerosis30:313–320, 1978

    Article  CAS  PubMed  Google Scholar 

  30. Larsson, A., Larsson, S.-E.: Light microscopic and ultrastructural observations on the short-term effects of ethylene-1-hydroxy-1,1-diphosphonate (EHDP) on rat tibia epiphysis, Acta Pathol. Microbiol. Scand. [A]84:17–27, 1976

    CAS  Google Scholar 

  31. Howell, D.S., Pita, J.C., Marquez, J.F., Gatter, R.A.: Demonstration of macromolecular inhibitor(s) of calcification in fluid from calcifying sites in cartilage. J. Clin. Invest.48:630–641, 1969

    Article  CAS  PubMed  Google Scholar 

  32. Fast, D.K., Felix, R., Dowse, C., Neuman, W.F., Fleisch, H.: The effects of diphosphonates on the growth and glycolysis of connective-tissue cells in culture, Biochem. J.172:97–107, 1978

    CAS  PubMed  Google Scholar 

  33. Walker, D.G.: Bone resorption restored in osteopetrotic mice by transplants of normal bone marrow and spleen cells. Science190:784–785, 1975

    CAS  PubMed  Google Scholar 

  34. Walker, D.G.: Spleen cells transmit osteopetrosis in mice, Science190:785–787, 1975

    CAS  PubMed  Google Scholar 

  35. Mundy, G.R., Varani, J., Orr, W., Gondek, M.D., Ward, P.A.: Resorbing bone is chemotactic for monocytes, Nature275:132–135, 1978

    Article  CAS  PubMed  Google Scholar 

  36. Marks, S.C.: Pathogenesis of osteopetrosis in theia rat: reduced resorption due to reduced osteoclast function, Am. J. Anat.138:165–190, 1973

    Article  PubMed  Google Scholar 

  37. Parfitt, A.M.: The actions of parathyroid hormone on bone: relation to bone remodeling and turnover, calcium homeostasis, and metabolic bone disease. Part I: Mechanisms of calcium transfer between blood and bone and their cellular basis: Morphological and kinetic approaches to bone turnover, Metabolism25:809–844, 1976

    Article  CAS  PubMed  Google Scholar 

  38. Morgan, D.B., Gasser, A., Largiadèr, U., Jung, A., Fleisch, H.: Effects of a diphosphonate on calcium metabolism in calcium-deprived rats, Am. J. Physiol.228:1750–1756, 1975

    CAS  PubMed  Google Scholar 

  39. Frijlink, W.B., Bijvoet, O.L.M., TeVelde, J., Heynen, G.: Treatment of Paget's disease with (3-amino-1-hydroxy-propylidene)-1,1-biphosphonate (APD), Lanceti:799–803, 1979

    Article  Google Scholar 

  40. Wuthier, R.E.: A zonal analysis of inorganic and organic constituents of the epiphysis during enchondral calcification, Calcif. Tissue Res.4:20–38, 1969

    Article  CAS  PubMed  Google Scholar 

  41. Reitsma, P.H., Bijvoet, O.L.M., Frijlink, W.B., Vismans, F.J.F.E., Van Breukelen, F.J.M.: Pharmacology of disodium (3-amino-1-hydroxypropylidene)-1,1-biphosphonate. In S.G. Massry (ed): Proceedings of the Fourth International Workshop on Phosphate and Other Minerals, 1979. Plenum Press, New York (in press)

    Google Scholar 

  42. Bijvoet, O.L.M., Hosking, D.J., Lemkes, H.H.P.J., Reitsma, P.H., Frijlink, W.B.: Development in the treatment of Paget's disease. In: Exerpta Med. Int. Congr. Ser. No. 421: Endocrinology of Calcium Metabolism, pp. 48–54. Excerpta Medica, Amsterdam, 1977

    Google Scholar 

  43. Van Breukelen, F.J.M., Bijvoet, O.L.M., Van Oosterom, A.T.: Inhibition of osteolytic bone lesions by (3-amino-1-hydroxypropylidene)-1,1-biphosphonate (APD), Lanceti:803–805, 1979

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Reitsma, P.H., Bijvoet, O.L.M., Verlinden-Ooms, H. et al. Kinetic studies of bone and mineral metabolism during treatment with (3-amino-1-hydroxypropylidene)-1,1-bisphosphonate (APD) in rats. Calcif Tissue Int 32, 145–157 (1980). https://doi.org/10.1007/BF02408534

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02408534

Key words

Navigation